Hepatitis B immunoglobulin-induced hypercoagulability complicating liver transplantation necessitating ECMO, rescue hepatectomy, and retransplantation
With the patient's written informed consent, we describe the course of a 55-year-old Asian male with hepatitis B cirrhosis (+HBsAg, MELD 25), hepatocellular carcinoma (HCC) status post ablation, and chronic kidney disease (non-dialysis dependent) undergoing split liver and kidney transplant from the same deceased donor. We administered hepatitis B immunoglobulin after hepatectomy. After renal reperfusion, the graft became mottled and was explanted with hyperacute rejection suspected. The hepatic graft appeared viable.
Source: Journal of Clinical Anesthesia - Category: Anesthesiology Authors: Paul N. Frank, Vivek V. Sharma, Avner Gereboff, Maha Guindi, Irene K. Kim, Robert Kariger Tags: Correspondence Source Type: research
More News: Anesthesia | Anesthesiology | Cancer & Oncology | Carcinoma | Chronic Kidney Disease | Cirrhosis | Dialysis | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Kidney Transplant | Kidney Transplantation | Liver | Liver Cancer | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology